Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD.

Bone. 2009 Nov;45(5):870-5. doi: 10.1016/j.bone.2009.07.015. Epub 2009 Jul 23.

PMID:
19631774
2.

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays.

Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR, Fraser WD, Vasikaran SD.

Ann Clin Biochem. 2006 Jan;43(Pt 1):23-30.

PMID:
16390606
3.

Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure.

Worth GK, Vasikaran SD, Retallack RW, Musk AA, Gutteridge DH.

Ann Clin Biochem. 2004 Mar;41(Pt 2):149-54.

PMID:
15025807
4.
5.

Parathyroid hormone is more stable in EDTA plasma than in serum.

Glendenning P, Laffer LL, Weber HK, Musk AA, Vasikaran SD.

Clin Chem. 2002 May;48(5):766-7. No abstract available.

6.

Preanalytical factors in the measurement of intact parathyroid hormone with the DPC IMMULITE assay.

Glendenning P, Musk AA, Taranto M, Vasikaran SD.

Clin Chem. 2002 Mar;48(3):566-7. No abstract available.

7.

Vitamin D insufficiency and hyperparathyroidism in Perth blood donors.

Vasikaran SD, Sturdy G, Musk AA, Flicker L.

Med J Aust. 2000 Apr 17;172(8):406-7. No abstract available.

PMID:
10840500
8.

Cardiac enzyme changes in myxedema coma.

Hickman PE, Silvester W, Musk AA, McLellan GH, Harris A.

Clin Chem. 1987 Apr;33(4):622-4.

9.

Weight reduction in a normal population.

Tofler OB, Musk AA, Woodings T, Atkin K, Meecham C, Bruce S, Mina L.

Med J Aust. 1981 Mar 7;1(5):240-1.

PMID:
7231314

Supplemental Content

Support Center